Here are five things to know:
1. In the fourth quarter, the U.S. orthopedics sales were $1.4 billion; international sales were $9.65 million. Worldwide sales dropped 1.5 percent to $2.3 billion. Full year sales grew 0.8 percent to $9.3 billion with U.S. sales reaching $5.5 billion and international sales hitting $3.8 billion.
2. U.S. hip sales reached $350 million in the fourth quarter and $1.3 billion for the full year. U.S. hip sales in the fourth quarter dropped 2.3 percent to $208 million, but full year sales in the U.S. grew 2.2 percent to $798 million.
3. Full year knee sales grew 1.9 percent to $1.5 billion, with U.S. sales hitting $943 million and international sales were $581 million. Fourth quarter knee sales dropped 2.5 percent to $395 million.
4. In the fourth quarter, trauma sales hit $654 worldwide, growing 4 percent to $394 million in the U.
S. Full year trauma sales were up 1.6 percent to $2.5 billion, with U.S. sales up 5.7 percent to $1.5 billion.
5. Spine and other sales slumped 3.1 percent in the fourth quarter, hitting $988 million. The full year spine and other sales were $3.8 billion, down 0.7 percent when compared with last year.
More articles on orthopedic devices:
Johnson & Johnson CEO Alex Gorsky: 5 things to know on 2017
Aurora Spine appoints Sarina Mason CFO: 4 insights
DePuy Synthes, Pacira partner on Exparel education: 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
